A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...
AI optimists counter that the technology is getting better at an astounding pace. But sceptics insist artificial intelligence ...